Rare Disease Our Approach to Gene Therapy and More Internal Medicine Advancing the Fight Anti Infectives New Drugs, Medicines & Therapies Products Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. ...
Rare Disease Internal Medicine Inflammation & Immunology Vaccines Oncology Anti Infectives Pipeline Snapshot as of April 29, 2025 00Phase 1 00Phase 2 00Phase 3 00Registration 00Total Download Complete Pipeline PDF Science Will Win This is our rallying cry as our scientists relentlessly pursue breakth...
our ambitions are big and our product pipeline has never been stronger. we’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere. to our investors why invest financial reports events and presentations stock information ...
We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development!
Research and Pipeline Social Responsibility Vaccines October 2024 10.22.2024 Corporate Partnerships Pfizer Supplies One Billionth Pneumococcal Conjugated Vaccine Dose for Vaccination of Children in Lower- Income Countries Through Gavi, the Vaccine Alliance ...
We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development! Find out more Latest News View All News Email Alerts To...
The first-quarter 2022 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to Pfizer’s R&D pipeline can be found on the Pfizer website. EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: “I am very proud of ...
This earnings release and the related attachments contain forward-looking statements about, among other topics, our anticipated operating and financial performance; reorganizations; business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipat...
Cell and gene therapies: Pipe dream to pipeline The cell and gene industry is gaining momentum, with a new wave of therapies promising to transform the way doctors treat, and even cure, disease. In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and ...
“We are entering 2024 with a solid foundation. We believe our commitment to execution, maximizing the performance of our new products, and delivering the next wave of pipeline innovation will fuel Pfizer’s growth and make a difference in the lives of patients everywhere.” ...